Microbix Biosystems Inc. (MBX) — Capital Reinvestment Ratio
Latest as of September 2025:
1.84x
Microbix Biosystems Inc. (MBX) has a Capital Reinvestment Ratio of 1.84x as of September 2025, meaning it reinvests 2% of its operating cash flow (CA$83.95K) in capital expenditures (CA$154.30K). See MBX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.84x
Capex / Operating Cash Flow
Operating Cash Flow
CA$83.95K
CAD
Capital Expenditures
CA$154.30K
CAD
Data as of
Sep 2025
Most recent filing
Microbix Biosystems Inc. Capital Reinvestment Ratio (2001–2024)
This chart tracks Microbix Biosystems Inc.'s Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Microbix Biosystems Inc. (2001–2024)
Year-by-year Capital Reinvestment Ratio for Microbix Biosystems Inc. from 2001 to 2024. For live market cap and broader valuation context, see Microbix Biosystems Inc. (MBX) total market value.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.44x | CA$4.35 Million | CA$1.91 Million | ▼ -25.0% |
| 2022 | 0.58x | CA$3.47 Million | CA$2.03 Million | ▼ -5.5% |
| 2021 | 0.62x | CA$2.11 Million | CA$1.30 Million | ▼ -99.3% |
| 2020 | 95.02x | CA$8.57K | CA$813.91K | ▲ +718.9% |
| 2019 | 11.60x | CA$44.37K | CA$514.80K | ▲ +437.9% |
| 2017 | 2.16x | CA$297.05K | CA$640.75K | ▲ +20.0% |
| 2016 | 1.80x | CA$913.31K | CA$1.64 Million | ▼ -77.9% |
| 2015 | 8.13x | CA$595.40K | CA$4.84 Million | ▲ +1438.2% |
| 2013 | 0.53x | CA$428.36K | CA$226.47K | ▼ -18.9% |
| 2005 | 0.65x | CA$372.31K | CA$242.65K | ▲ +200.2% |
| 2004 | 0.22x | CA$444.57K | CA$96.53K | ▼ -30.3% |
| 2002 | 0.31x | CA$106.20K | CA$33.11K | ▲ +82.1% |
| 2001 | 0.17x | CA$353.56K | CA$60.53K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow